カテゴリ： 世界, 医療/バイオ, Market Monitor Global

片頭痛予防治療のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他

■ 英語タイトル：Preventive Treatment of Migraines Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14532）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14532
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[片頭痛予防治療のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の片頭痛予防治療市場規模と予測を収録しています。・世界の片頭痛予防治療市場：売上、2018年-2023年、2024年-2029年
・世界の片頭痛予防治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の片頭痛予防治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カルシウムチャネル遮断薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

片頭痛予防治療のグローバル主要企業は、Biohaven、 ELI LILLY AND CO、 ABBVIE INC、 Johnson and Johnson、 Cipla Limited、 Torrent Pharmaceuticals、 Aa Pharma、 Karnataka Antibiotics and Pharmaceuticals、 Cadila Pharmaceuticals、 Orchid Chemicals and Pharmaceuticals、 Fdc、 Alkem Laboratories、 Intas Pharmaceuticals、 PFIZER INCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、片頭痛予防治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の片頭痛予防治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の片頭痛予防治療市場：タイプ別市場シェア、2022年
・カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他

世界の片頭痛予防治療市場：用途別、2018年-2023年、2024年-2029年
世界の片頭痛予防治療市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の片頭痛予防治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の片頭痛予防治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における片頭痛予防治療のグローバル売上、2018年-2023年
・主要企業における片頭痛予防治療のグローバル売上シェア、2022年
・主要企業における片頭痛予防治療のグローバル販売量、2018年-2023年
・主要企業における片頭痛予防治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Biohaven、 ELI LILLY AND CO、 ABBVIE INC、 Johnson and Johnson、 Cipla Limited、 Torrent Pharmaceuticals、 Aa Pharma、 Karnataka Antibiotics and Pharmaceuticals、 Cadila Pharmaceuticals、 Orchid Chemicals and Pharmaceuticals、 Fdc、 Alkem Laboratories、 Intas Pharmaceuticals、 PFIZER INC

*************************************************************

・調査・分析レポートの概要
片頭痛予防治療市場の定義
市場セグメント
世界の片頭痛予防治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の片頭痛予防治療市場規模
世界の片頭痛予防治療市場規模：2022年 VS 2029年
世界の片頭痛予防治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの片頭痛予防治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の片頭痛予防治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他
片頭痛予防治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
片頭痛予防治療の用途別グローバル売上・予測

・地域別市場分析
地域別片頭痛予防治療市場規模 2022年と2029年
地域別片頭痛予防治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Biohaven、 ELI LILLY AND CO、 ABBVIE INC、 Johnson and Johnson、 Cipla Limited、 Torrent Pharmaceuticals、 Aa Pharma、 Karnataka Antibiotics and Pharmaceuticals、 Cadila Pharmaceuticals、 Orchid Chemicals and Pharmaceuticals、 Fdc、 Alkem Laboratories、 Intas Pharmaceuticals、 PFIZER INC
...

This research report provides a comprehensive analysis of the Preventive Treatment of Migraines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Preventive Treatment of Migraines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Preventive Treatment of Migraines, challenges faced by the industry, and potential opportunities for market players.
The global Preventive Treatment of Migraines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Preventive Treatment of Migraines market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Preventive Treatment of Migraines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Preventive Treatment of Migraines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private＆government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Preventive Treatment of Migraines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Preventive Treatment of Migraines market.
Market Overview: The report provides a comprehensive overview of the Preventive Treatment of Migraines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Calcium Channel Blockers, Anti-epileptic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Preventive Treatment of Migraines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Preventive Treatment of Migraines market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Preventive Treatment of Migraines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Preventive Treatment of Migraines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Preventive Treatment of Migraines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Preventive Treatment of Migraines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Preventive Treatment of Migraines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Preventive Treatment of Migraines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Preventive Treatment of Migraines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Calcium Channel Blockers
Anti-epileptic Drugs
β-blockers
Calcium Channel Modulators
Antidepressants
Other
Market segment by Application
Hospital
Clinic
Other
Global Preventive Treatment of Migraines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East＆Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East＆Africa
Major players covered
Biohaven
ELI LILLY AND CO
ABBVIE INC
Johnson and Johnson
Cipla Limited
Torrent Pharmaceuticals
Aa Pharma
Karnataka Antibiotics and Pharmaceuticals
Cadila Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
Fdc
Alkem Laboratories
Intas Pharmaceuticals
PFIZER INC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Preventive Treatment of Migraines, market overview.
Chapter 2: Global Preventive Treatment of Migraines market size in revenue and volume.
Chapter 3: Detailed analysis of Preventive Treatment of Migraines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Preventive Treatment of Migraines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Preventive Treatment of Migraines capacity by region＆country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research＆Analysis Reports
1.1 Preventive Treatment of Migraines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preventive Treatment of Migraines Market Overview
1.4 Features＆Benefits of This Report
1.5 Methodology＆Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions＆Caveats
2 Global Preventive Treatment of Migraines Overall Market Size
2.1 Global Preventive Treatment of Migraines Market Size: 2022 VS 2029
2.2 Global Preventive Treatment of Migraines Revenue, Prospects＆Forecasts: 2018-2029
2.3 Global Preventive Treatment of Migraines Sales: 2018-2029
3 Company Landscape
3.1 Top Preventive Treatment of Migraines Players in Global Market
3.2 Top Global Preventive Treatment of Migraines Companies Ranked by Revenue
3.3 Global Preventive Treatment of Migraines Revenue by Companies
3.4 Global Preventive Treatment of Migraines Sales by Companies
3.5 Global Preventive Treatment of Migraines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Preventive Treatment of Migraines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Preventive Treatment of Migraines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Preventive Treatment of Migraines Players in Global Market
3.8.1 List of Global Tier 1 Preventive Treatment of Migraines Companies
3.8.2 List of Global Tier 2 and Tier 3 Preventive Treatment of Migraines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Preventive Treatment of Migraines Market Size Markets, 2022＆2029
4.1.2 Calcium Channel Blockers
4.1.3 Anti-epileptic Drugs
4.1.4 β-blockers
4.1.5 Calcium Channel Modulators
4.1.6 Antidepressants
4.1.7 Other
4.2 By Type – Global Preventive Treatment of Migraines Revenue＆Forecasts
4.2.1 By Type – Global Preventive Treatment of Migraines Revenue, 2018-2023
4.2.2 By Type – Global Preventive Treatment of Migraines Revenue, 2024-2029
4.2.3 By Type – Global Preventive Treatment of Migraines Revenue Market Share, 2018-2029
4.3 By Type – Global Preventive Treatment of Migraines Sales＆Forecasts
4.3.1 By Type – Global Preventive Treatment of Migraines Sales, 2018-2023
4.3.2 By Type – Global Preventive Treatment of Migraines Sales, 2024-2029
4.3.3 By Type – Global Preventive Treatment of Migraines Sales Market Share, 2018-2029
4.4 By Type – Global Preventive Treatment of Migraines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Preventive Treatment of Migraines Market Size, 2022＆2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Preventive Treatment of Migraines Revenue＆Forecasts
5.2.1 By Application – Global Preventive Treatment of Migraines Revenue, 2018-2023
5.2.2 By Application – Global Preventive Treatment of Migraines Revenue, 2024-2029
5.2.3 By Application – Global Preventive Treatment of Migraines Revenue Market Share, 2018-2029
5.3 By Application – Global Preventive Treatment of Migraines Sales＆Forecasts
5.3.1 By Application – Global Preventive Treatment of Migraines Sales, 2018-2023
5.3.2 By Application – Global Preventive Treatment of Migraines Sales, 2024-2029
5.3.3 By Application – Global Preventive Treatment of Migraines Sales Market Share, 2018-2029
5.4 By Application – Global Preventive Treatment of Migraines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Preventive Treatment of Migraines Market Size, 2022＆2029
6.2 By Region – Global Preventive Treatment of Migraines Revenue＆Forecasts
6.2.1 By Region – Global Preventive Treatment of Migraines Revenue, 2018-2023
6.2.2 By Region – Global Preventive Treatment of Migraines Revenue, 2024-2029
6.2.3 By Region – Global Preventive Treatment of Migraines Revenue Market Share, 2018-2029
6.3 By Region – Global Preventive Treatment of Migraines Sales＆Forecasts
6.3.1 By Region – Global Preventive Treatment of Migraines Sales, 2018-2023
6.3.2 By Region – Global Preventive Treatment of Migraines Sales, 2024-2029
6.3.3 By Region – Global Preventive Treatment of Migraines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Preventive Treatment of Migraines Revenue, 2018-2029
6.4.2 By Country – North America Preventive Treatment of Migraines Sales, 2018-2029
6.4.3 US Preventive Treatment of Migraines Market Size, 2018-2029
6.4.4 Canada Preventive Treatment of Migraines Market Size, 2018-2029
6.4.5 Mexico Preventive Treatment of Migraines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Preventive Treatment of Migraines Revenue, 2018-2029
6.5.2 By Country – Europe Preventive Treatment of Migraines Sales, 2018-2029
6.5.3 Germany Preventive Treatment of Migraines Market Size, 2018-2029
6.5.4 France Preventive Treatment of Migraines Market Size, 2018-2029
6.5.5 U.K. Preventive Treatment of Migraines Market Size, 2018-2029
6.5.6 Italy Preventive Treatment of Migraines Market Size, 2018-2029
6.5.7 Russia Preventive Treatment of Migraines Market Size, 2018-2029
6.5.8 Nordic Countries Preventive Treatment of Migraines Market Size, 2018-2029
6.5.9 Benelux Preventive Treatment of Migraines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Preventive Treatment of Migraines Revenue, 2018-2029
6.6.2 By Region – Asia Preventive Treatment of Migraines Sales, 2018-2029
6.6.3 China Preventive Treatment of Migraines Market Size, 2018-2029
6.6.4 Japan Preventive Treatment of Migraines Market Size, 2018-2029
6.6.5 South Korea Preventive Treatment of Migraines Market Size, 2018-2029
6.6.6 Southeast Asia Preventive Treatment of Migraines Market Size, 2018-2029
6.6.7 India Preventive Treatment of Migraines Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Preventive Treatment of Migraines Revenue, 2018-2029
6.7.2 By Country – South America Preventive Treatment of Migraines Sales, 2018-2029
6.7.3 Brazil Preventive Treatment of Migraines Market Size, 2018-2029
6.7.4 Argentina Preventive Treatment of Migraines Market Size, 2018-2029
6.8 Middle East＆Africa
6.8.1 By Country – Middle East＆Africa Preventive Treatment of Migraines Revenue, 2018-2029
6.8.2 By Country – Middle East＆Africa Preventive Treatment of Migraines Sales, 2018-2029
6.8.3 Turkey Preventive Treatment of Migraines Market Size, 2018-2029
6.8.4 Israel Preventive Treatment of Migraines Market Size, 2018-2029
6.8.5 Saudi Arabia Preventive Treatment of Migraines Market Size, 2018-2029
6.8.6 UAE Preventive Treatment of Migraines Market Size, 2018-2029
7 Manufacturers＆Brands Profiles
7.1 Biohaven
7.1.1 Biohaven Company Summary
7.1.2 Biohaven Business Overview
7.1.3 Biohaven Preventive Treatment of Migraines Major Product Offerings
7.1.4 Biohaven Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.1.5 Biohaven Key News＆Latest Developments
7.2 ELI LILLY AND CO
7.2.1 ELI LILLY AND CO Company Summary
7.2.2 ELI LILLY AND CO Business Overview
7.2.3 ELI LILLY AND CO Preventive Treatment of Migraines Major Product Offerings
7.2.4 ELI LILLY AND CO Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.2.5 ELI LILLY AND CO Key News＆Latest Developments
7.3 ABBVIE INC
7.3.1 ABBVIE INC Company Summary
7.3.2 ABBVIE INC Business Overview
7.3.3 ABBVIE INC Preventive Treatment of Migraines Major Product Offerings
7.3.4 ABBVIE INC Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.3.5 ABBVIE INC Key News＆Latest Developments
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Company Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Preventive Treatment of Migraines Major Product Offerings
7.4.4 Johnson and Johnson Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.4.5 Johnson and Johnson Key News＆Latest Developments
7.5 Cipla Limited
7.5.1 Cipla Limited Company Summary
7.5.2 Cipla Limited Business Overview
7.5.3 Cipla Limited Preventive Treatment of Migraines Major Product Offerings
7.5.4 Cipla Limited Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.5.5 Cipla Limited Key News＆Latest Developments
7.6 Torrent Pharmaceuticals
7.6.1 Torrent Pharmaceuticals Company Summary
7.6.2 Torrent Pharmaceuticals Business Overview
7.6.3 Torrent Pharmaceuticals Preventive Treatment of Migraines Major Product Offerings
7.6.4 Torrent Pharmaceuticals Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.6.5 Torrent Pharmaceuticals Key News＆Latest Developments
7.7 Aa Pharma
7.7.1 Aa Pharma Company Summary
7.7.2 Aa Pharma Business Overview
7.7.3 Aa Pharma Preventive Treatment of Migraines Major Product Offerings
7.7.4 Aa Pharma Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.7.5 Aa Pharma Key News＆Latest Developments
7.8 Karnataka Antibiotics and Pharmaceuticals
7.8.1 Karnataka Antibiotics and Pharmaceuticals Company Summary
7.8.2 Karnataka Antibiotics and Pharmaceuticals Business Overview
7.8.3 Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Major Product Offerings
7.8.4 Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.8.5 Karnataka Antibiotics and Pharmaceuticals Key News＆Latest Developments
7.9 Cadila Pharmaceuticals
7.9.1 Cadila Pharmaceuticals Company Summary
7.9.2 Cadila Pharmaceuticals Business Overview
7.9.3 Cadila Pharmaceuticals Preventive Treatment of Migraines Major Product Offerings
7.9.4 Cadila Pharmaceuticals Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.9.5 Cadila Pharmaceuticals Key News＆Latest Developments
7.10 Orchid Chemicals and Pharmaceuticals
7.10.1 Orchid Chemicals and Pharmaceuticals Company Summary
7.10.2 Orchid Chemicals and Pharmaceuticals Business Overview
7.10.3 Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Major Product Offerings
7.10.4 Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.10.5 Orchid Chemicals and Pharmaceuticals Key News＆Latest Developments
7.11 Fdc
7.11.1 Fdc Company Summary
7.11.2 Fdc Business Overview
7.11.3 Fdc Preventive Treatment of Migraines Major Product Offerings
7.11.4 Fdc Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.11.5 Fdc Key News＆Latest Developments
7.12 Alkem Laboratories
7.12.1 Alkem Laboratories Company Summary
7.12.2 Alkem Laboratories Business Overview
7.12.3 Alkem Laboratories Preventive Treatment of Migraines Major Product Offerings
7.12.4 Alkem Laboratories Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.12.5 Alkem Laboratories Key News＆Latest Developments
7.13 Intas Pharmaceuticals
7.13.1 Intas Pharmaceuticals Company Summary
7.13.2 Intas Pharmaceuticals Business Overview
7.13.3 Intas Pharmaceuticals Preventive Treatment of Migraines Major Product Offerings
7.13.4 Intas Pharmaceuticals Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.13.5 Intas Pharmaceuticals Key News＆Latest Developments
7.14 PFIZER INC
7.14.1 PFIZER INC Company Summary
7.14.2 PFIZER INC Business Overview
7.14.3 PFIZER INC Preventive Treatment of Migraines Major Product Offerings
7.14.4 PFIZER INC Preventive Treatment of Migraines Sales and Revenue in Global (2018-2023)
7.14.5 PFIZER INC Key News＆Latest Developments
8 Global Preventive Treatment of Migraines Production Capacity, Analysis
8.1 Global Preventive Treatment of Migraines Production Capacity, 2018-2029
8.2 Preventive Treatment of Migraines Production Capacity of Key Manufacturers in Global Market
8.3 Global Preventive Treatment of Migraines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities＆Trends
9.2 Market Drivers
9.3 Market Restraints
10 Preventive Treatment of Migraines Supply Chain Analysis
10.1 Preventive Treatment of Migraines Industry Value Chain
10.2 Preventive Treatment of Migraines Upstream Market
10.3 Preventive Treatment of Migraines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Preventive Treatment of Migraines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Preventive Treatment of Migraines in Global Market
Table 2. Top Preventive Treatment of Migraines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Preventive Treatment of Migraines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Preventive Treatment of Migraines Revenue Share by Companies, 2018-2023
Table 5. Global Preventive Treatment of Migraines Sales by Companies, (K Units), 2018-2023
Table 6. Global Preventive Treatment of Migraines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Preventive Treatment of Migraines Price (2018-2023)＆(US$/Unit)
Table 8. Global Manufacturers Preventive Treatment of Migraines Product Type
Table 9. List of Global Tier 1 Preventive Treatment of Migraines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preventive Treatment of Migraines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Preventive Treatment of Migraines Revenue, (US$, Mn), 2022＆2029
Table 12. By Type - Global Preventive Treatment of Migraines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Preventive Treatment of Migraines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Preventive Treatment of Migraines Sales (K Units), 2018-2023
Table 15. By Type - Global Preventive Treatment of Migraines Sales (K Units), 2024-2029
Table 16. By Application – Global Preventive Treatment of Migraines Revenue, (US$, Mn), 2022＆2029
Table 17. By Application - Global Preventive Treatment of Migraines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Preventive Treatment of Migraines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Preventive Treatment of Migraines Sales (K Units), 2018-2023
Table 20. By Application - Global Preventive Treatment of Migraines Sales (K Units), 2024-2029
Table 21. By Region – Global Preventive Treatment of Migraines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Preventive Treatment of Migraines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Preventive Treatment of Migraines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Preventive Treatment of Migraines Sales (K Units), 2018-2023
Table 25. By Region - Global Preventive Treatment of Migraines Sales (K Units), 2024-2029
Table 26. By Country - North America Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Preventive Treatment of Migraines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Preventive Treatment of Migraines Sales, (K Units), 2018-2023
Table 29. By Country - North America Preventive Treatment of Migraines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Preventive Treatment of Migraines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Preventive Treatment of Migraines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Preventive Treatment of Migraines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Preventive Treatment of Migraines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Preventive Treatment of Migraines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Preventive Treatment of Migraines Sales, (K Units), 2024-2029
Table 38. By Country - South America Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Preventive Treatment of Migraines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Preventive Treatment of Migraines Sales, (K Units), 2018-2023
Table 41. By Country - South America Preventive Treatment of Migraines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East＆Africa Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East＆Africa Preventive Treatment of Migraines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East＆Africa Preventive Treatment of Migraines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East＆Africa Preventive Treatment of Migraines Sales, (K Units), 2024-2029
Table 46. Biohaven Company Summary
Table 47. Biohaven Preventive Treatment of Migraines Product Offerings
Table 48. Biohaven Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Biohaven Key News＆Latest Developments
Table 50. ELI LILLY AND CO Company Summary
Table 51. ELI LILLY AND CO Preventive Treatment of Migraines Product Offerings
Table 52. ELI LILLY AND CO Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. ELI LILLY AND CO Key News＆Latest Developments
Table 54. ABBVIE INC Company Summary
Table 55. ABBVIE INC Preventive Treatment of Migraines Product Offerings
Table 56. ABBVIE INC Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. ABBVIE INC Key News＆Latest Developments
Table 58. Johnson and Johnson Company Summary
Table 59. Johnson and Johnson Preventive Treatment of Migraines Product Offerings
Table 60. Johnson and Johnson Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Johnson and Johnson Key News＆Latest Developments
Table 62. Cipla Limited Company Summary
Table 63. Cipla Limited Preventive Treatment of Migraines Product Offerings
Table 64. Cipla Limited Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Cipla Limited Key News＆Latest Developments
Table 66. Torrent Pharmaceuticals Company Summary
Table 67. Torrent Pharmaceuticals Preventive Treatment of Migraines Product Offerings
Table 68. Torrent Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Torrent Pharmaceuticals Key News＆Latest Developments
Table 70. Aa Pharma Company Summary
Table 71. Aa Pharma Preventive Treatment of Migraines Product Offerings
Table 72. Aa Pharma Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Aa Pharma Key News＆Latest Developments
Table 74. Karnataka Antibiotics and Pharmaceuticals Company Summary
Table 75. Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Product Offerings
Table 76. Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Karnataka Antibiotics and Pharmaceuticals Key News＆Latest Developments
Table 78. Cadila Pharmaceuticals Company Summary
Table 79. Cadila Pharmaceuticals Preventive Treatment of Migraines Product Offerings
Table 80. Cadila Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Cadila Pharmaceuticals Key News＆Latest Developments
Table 82. Orchid Chemicals and Pharmaceuticals Company Summary
Table 83. Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Product Offerings
Table 84. Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Orchid Chemicals and Pharmaceuticals Key News＆Latest Developments
Table 86. Fdc Company Summary
Table 87. Fdc Preventive Treatment of Migraines Product Offerings
Table 88. Fdc Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Fdc Key News＆Latest Developments
Table 90. Alkem Laboratories Company Summary
Table 91. Alkem Laboratories Preventive Treatment of Migraines Product Offerings
Table 92. Alkem Laboratories Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Alkem Laboratories Key News＆Latest Developments
Table 94. Intas Pharmaceuticals Company Summary
Table 95. Intas Pharmaceuticals Preventive Treatment of Migraines Product Offerings
Table 96. Intas Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Intas Pharmaceuticals Key News＆Latest Developments
Table 98. PFIZER INC Company Summary
Table 99. PFIZER INC Preventive Treatment of Migraines Product Offerings
Table 100. PFIZER INC Preventive Treatment of Migraines Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. PFIZER INC Key News＆Latest Developments
Table 102. Preventive Treatment of Migraines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Preventive Treatment of Migraines Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Preventive Treatment of Migraines Production by Region, 2018-2023 (K Units)
Table 105. Global Preventive Treatment of Migraines Production by Region, 2024-2029 (K Units)
Table 106. Preventive Treatment of Migraines Market Opportunities＆Trends in Global Market
Table 107. Preventive Treatment of Migraines Market Drivers in Global Market
Table 108. Preventive Treatment of Migraines Market Restraints in Global Market
Table 109. Preventive Treatment of Migraines Raw Materials
Table 110. Preventive Treatment of Migraines Raw Materials Suppliers in Global Market
Table 111. Typical Preventive Treatment of Migraines Downstream
Table 112. Preventive Treatment of Migraines Downstream Clients in Global Market
Table 113. Preventive Treatment of Migraines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Preventive Treatment of Migraines Segment by Type in 2022
Figure 2. Preventive Treatment of Migraines Segment by Application in 2022
Figure 3. Global Preventive Treatment of Migraines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Preventive Treatment of Migraines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Preventive Treatment of Migraines Revenue, 2018-2029 (US$, Mn)
Figure 7. Preventive Treatment of Migraines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Preventive Treatment of Migraines Revenue in 2022
Figure 9. By Type - Global Preventive Treatment of Migraines Revenue, (US$, Mn), 2022＆2029
Figure 10. By Type - Global Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 12. By Type - Global Preventive Treatment of Migraines Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Preventive Treatment of Migraines Revenue, (US$, Mn), 2022＆2029
Figure 14. By Application - Global Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 16. By Application - Global Preventive Treatment of Migraines Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Preventive Treatment of Migraines Revenue, (US$, Mn), 2022＆2029
Figure 18. By Region - Global Preventive Treatment of Migraines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 21. By Country - North America Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 23. US Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 28. Germany Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 29. France Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 37. China Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 41. India Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 44. Brazil Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East＆Africa Preventive Treatment of Migraines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East＆Africa Preventive Treatment of Migraines Sales Market Share, 2018-2029
Figure 48. Turkey Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Preventive Treatment of Migraines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Preventive Treatment of Migraines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Preventive Treatment of Migraines by Region, 2022 VS 2029
Figure 54. Preventive Treatment of Migraines Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 処方鎮痛薬のグローバル市場展望 2023年-2029年：処方薬 NSAIDs、オピオイド、抗てんかん薬、抗うつ薬、その他
  • 双極性障害治療のグローバル市場展望 2023年-2029年：気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬
  • 慢性疲労症候群治療薬のグローバル市場展望 2023年-2029年：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬
  • 末梢血管用拡張薬のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、α-アドレナリン遮断薬、カリウムチャネル活性化薬、その他
  • 慢性腎臓病治療薬のグローバル市場展望 2023年-2029年：ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14532 )"片頭痛予防治療のグローバル市場展望 2023年-2029年：カルシウムチャネル遮断薬、抗てんかん薬、β遮断薬、カルシウムチャネル調節薬、抗うつ薬、その他" (英文：Preventive Treatment of Migraines Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。